WELL - Welltower Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Toledo,
United States
Type: Equity
WELL price evolution
WELL
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2863.6 | $2478.34 | $2076.08 | |
| Short term investments | ||||
| Net receivables | $1481.3 | $1521.88 | $1529.84 | $1455.32 |
| Inventory | ||||
| Total current assets | $5046.24 | $4298.51 | $3907.96 | $3448.96 |
| Long term investments | ||||
| Property, plant & equipment | $41876.83 | $37579.38 | $37331.35 | $37414.33 |
| Goodwill & intangible assets | $68.32 | $68.32 | $68.32 | |
| Total noncurrent assets | ||||
| Total investments | $3500.76 | $3145.74 | $2998.12 | |
| Total assets | $48953.7 | $45533.94 | $44553.58 | $44012.17 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $2034.76 | $1909.59 | $1719.99 | $1904.89 |
| Long term debt | $15854.94 | $13935.77 | $14285.69 | $15735.55 |
| Total noncurrent liabilities | ||||
| Total debt | $14329.44 | $14586.47 | $16118.78 | |
| Total liabilities | $18619.42 | $15845.36 | $16005.68 | $17640.44 |
| Shareholders' equity | ||||
| Retained earnings | -$7924.85 | -$7965.58 | -$7854.11 | -$7628.73 |
| Other shareholder equity | -$195.14 | -$246.46 | -$180.84 | -$163.16 |
| Total shareholder equity | $28976.43 | $27547.94 | $25404.38 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2076.08 | $722.29 | $346.75 | $2021.04 |
| Short term investments | ||||
| Net receivables | $1455.32 | $1452.89 | $1169.1 | $973.1 |
| Inventory | ||||
| Total current assets | $3448.96 | $2084.57 | $1428.73 | $3345.07 |
| Long term investments | $946.23 | |||
| Property, plant & equipment | $37414.33 | $34149.94 | $31218.43 | $28031.58 |
| Goodwill & intangible assets | $68.32 | $68.32 | $68.32 | $68.32 |
| Total noncurrent assets | ||||
| Total investments | $2998.12 | $2390.63 | $2107.72 | $1389.61 |
| Total assets | $44012.17 | $37893.23 | $34910.32 | $32483.64 |
| Current liabilities | ||||
| Accounts payable | $101.59 | |||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1904.89 | $1837.68 | $1669.82 | $502.33 |
| Long term debt | $15735.55 | $14661.55 | $14242.64 | $13798.72 |
| Total noncurrent liabilities | ||||
| Total debt | $16118.78 | $14963.91 | $14676.9 | $14216.99 |
| Total liabilities | $17640.44 | $17598.42 | $15912.45 | $15258.58 |
| Shareholders' equity | ||||
| Retained earnings | -$7628.73 | -$6709.15 | -$5717.18 | -$5016.12 |
| Other shareholder equity | -$163.16 | -$119.71 | -$121.32 | -$148.5 |
| Total shareholder equity | $25404.38 | $20294.81 | $17636 | $15972.72 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2055.66 | $1824.88 | $1859.74 | $1749.78 |
| Cost of revenue | $1111.3 | $1096.91 | $1036.08 | |
| Gross Profit | $850.08 | $713.59 | $762.83 | $713.7 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $55.56 | $53.32 | $44.33 | |
| Total operating expenses | $513.23 | $488.03 | $474.6 | $471.66 |
| Operating income | $225.56 | $288.23 | $242.04 | |
| Income from continuing operations | ||||
| EBIT | $389.24 | $280.65 | $233.72 | |
| Income tax expense | -$4.71 | $1.1 | $6.19 | -$4.77 |
| Interest expense | -$129.14 | $133.42 | $147.32 | $154.57 |
| Net income | ||||
| Net income | $449.85 | $254.71 | $127.15 | $83.91 |
| Income (for common shares) | $254.71 | $127.15 | $83.91 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6637.99 | $5860.61 | $4742.11 | $4605.97 |
| Cost of revenue | $3947.78 | $3558.77 | $2774.56 | $2597.82 |
| Gross Profit | $2690.22 | $2301.84 | $1967.55 | $2008.14 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $179.09 | $150.39 | $126.73 | $128.39 |
| Total operating expenses | $1732.32 | $1598.58 | $1249.81 | $1383.82 |
| Operating income | $957.9 | $703.26 | $717.75 | $624.32 |
| Income from continuing operations | ||||
| EBIT | $954.3 | $677.98 | $834.7 | $1503.2 |
| Income tax expense | $6.36 | $7.25 | $8.71 | $9.97 |
| Interest expense | $607.85 | $529.52 | $489.85 | $514.39 |
| Net income | ||||
| Net income | $340.09 | $141.21 | $336.14 | $978.84 |
| Income (for common shares) | $340.09 | $141.21 | $336.14 | $978.84 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $254.71 | $127.15 | $83.91 | |
| Operating activities | ||||
| Depreciation | $382.05 | $365.86 | $380.73 | |
| Business acquisitions & disposals | -$575.31 | -$156.56 | -$2557.01 | |
| Stock-based compensation | $10.35 | $12.05 | $8.42 | |
| Total cash flows from operations | $605.42 | $406.81 | $370.5 | |
| Investing activities | ||||
| Capital expenditures | -$307.51 | -$319.44 | -$455.06 | |
| Investments | -$381.51 | -$92.04 | -$117.57 | |
| Total cash flows from investing | -$3309.22 | -$1278.81 | -$580.93 | -$3144.19 |
| Financing activities | ||||
| Dividends paid | -$1127.05 | -$366.09 | -$352.18 | -$338.29 |
| Sale and purchase of stock | $1603.86 | $2416.48 | $2745.07 | |
| Net borrowings | -$99.47 | -$1481.45 | -$299.08 | |
| Total cash flows from financing | $3315.29 | $1059.12 | $578.57 | $2137.54 |
| Effect of exchange rate | $5.05 | -$0.46 | -$2.19 | $25.51 |
| Change in cash and equivalents | $1708.33 | $385.26 | $402.25 | -$610.63 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $340.09 | $141.21 | $336.14 | $978.84 |
| Operating activities | ||||
| Depreciation | $1401.1 | $1310.37 | $1037.57 | $1038.44 |
| Business acquisitions & disposals | -$3752.01 | -$2770.62 | -$4193.42 | -$1266.71 |
| Stock-based compensation | $37.2 | $26.15 | $17.81 | $28.32 |
| Total cash flows from operations | $1601.86 | $1328.71 | $1275.33 | $1364.76 |
| Investing activities | ||||
| Capital expenditures | -$1435.88 | -$908.26 | $369.77 | $3853.7 |
| Investments | -$469.16 | $5.55 | -$673.26 | -$221.59 |
| Total cash flows from investing | -$5707.74 | -$3703.82 | -$4516.27 | $2347.93 |
| Financing activities | ||||
| Dividends paid | -$1260.58 | -$1131.53 | -$1035.91 | -$1119.23 |
| Sale and purchase of stock | $6010.13 | $3667.85 | $2348.2 | $587.66 |
| Net borrowings | $655.04 | $371.3 | $320.76 | -$1198.24 |
| Total cash flows from financing | $5448.65 | $2761.28 | $1567.66 | -$2080.86 |
| Effect of exchange rate | $11.03 | -$10.63 | -$1.01 | $3.45 |
| Change in cash and equivalents | $1353.79 | $375.54 | -$1674.29 | $1635.28 |
News
Fundamentals
| Market cap | $84.40B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 618.40M |
| Revenue | $7.49B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $915.62M |
| Revenue Q/Q | 23.69% |
| Revenue Y/Y | 16.91% |
| P/E ratio | 92.18 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 11.27 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $1.48 |
|---|---|
| ROA | 2.00% |
| ROE | N/A |
| Debt/Equity | 0.69 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.48 |
| Quick ratio | N/A |